Cytokine Release Syndrome: Current Perspectives

Chimeric antigen receptor T cell (CART) therapy represents a novel and a paradigm-shifting approach to treating cancer. Recent clinical successes have widened the applicability of CD19 CART cells for the treatment of relapsed/refractory B-cell NHL, namely tisagenleclucel and axicabtagene ciloleucel....

Descripción completa

Detalles Bibliográficos
Autores principales: Murthy, Hemant, Iqbal, Madiha, Chavez, Julio C, Kharfan-Dabaja, Mohamed A
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825470/
https://www.ncbi.nlm.nih.gov/pubmed/31754614
http://dx.doi.org/10.2147/ITT.S202015

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6825470/
https://www.ncbi.nlm.nih.gov/pubmed/31754614
http://dx.doi.org/10.2147/ITT.S202015

Ejemplares similares